Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate whether treatment with (SEROQUEL SR)
quetiapine fumarate sustained release (SR) for 9 weeks compared to placebo will improve
depressive symptoms in elderly patients with major depressive disorder.
PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation
was changed to XR after consultation with FDA.